Details for New Drug Application (NDA): 213218
✉ Email this page to a colleague
The generic ingredient in SOAANZ is torsemide. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the torsemide profile page.
Summary for 213218
Tradename: | SOAANZ |
Applicant: | Sarfe Pharms |
Ingredient: | torsemide |
Patents: | 1 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 213218
Physiological Effect | Increased Diuresis at Loop of Henle |
Suppliers and Packaging for NDA: 213218
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SOAANZ | torsemide | TABLET;ORAL | 213218 | NDA | Sarfez Pharmaceuticals Inc | 73502-286 | 73502-286-15 | 5 BLISTER PACK in 1 CARTON (73502-286-15) / 6 TABLET, FILM COATED in 1 BLISTER PACK (73502-286-09) |
SOAANZ | torsemide | TABLET;ORAL | 213218 | NDA | Sarfez Pharmaceuticals Inc | 73502-287 | 73502-287-16 | 5 BLISTER PACK in 1 CARTON (73502-287-16) / 6 TABLET, FILM COATED in 1 BLISTER PACK (73502-287-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jun 14, 2021 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Oct 6, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Jun 14, 2021 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Try a Trial | Patent Expiration: | Oct 6, 2033 | Product Flag? | Y | Substance Flag? | Delist Request? |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Nov 17, 2021 | TE: | RLD: | Yes |
Complete Access Available with Subscription